Reflections on the BIS Quarterly Review (March 2026)
Synthetic risk transfers (SRTs) are no longer a niche capital tool. They are becoming a structural feature of modern bank balance sheet management. The latest BIS Quarterly Review confirms what market participants have observed over the past few years: the market is scaling rapidly, investor demand is deepening, and the use cases are broadening.
At the same time, the report highlights a more important shift. SRTs are moving from an opportunistic optimisation tool to something that, if not carefully managed, could carry system-wide implications.
The numbers are telling. Since 2016, SRT issuance has increased fivefold, with close to €800 billion of loans now protected globally. While still small relative to total lending, the trajectory matters more than the level.
What is particularly notable is not just growth, but who is using SRTs and why.
SRT issuance is concentrated among larger, capital-constrained banks, where the transactions are not simply tactical but increasingly embedded in capital planning. For these institutions, SRTs are no longer about marginal capital relief—they are about enabling lending capacity, improving return on equity, and actively managing portfolio risk.
This is a structural shift. Once SRTs become part of the capital stack, they are no longer optional.
A recurring theme in the BIS analysis is the growing and diversifying investor base. Credit funds, asset managers and institutional investors are increasingly comfortable underwriting bank-originated risk, attracted by strong risk-adjusted returns and portfolio diversification.
From a market perspective, this is not where the bottleneck lies.
If anything, investor appetite has proven resilient—even in volatile environments—supported by relatively conservative leverage, closed-end fund structures and a tendency to hold positions to maturity.
The implication is clear:
future growth in SRT is unlikely to be constrained by demand, but by structure and regulation.
The BIS is right to highlight that current risks remain modest. But the more interesting point is where risks could emerge as the market scales.
Three areas stand out.
1. Flowback- or rollover risk and hidden procyclicality
As banks integrate SRTs into capital planning, they implicitly assume continued access to the market. This introduces a form of rollover risk that is not always visible.
In benign conditions, this works well. In stress, however, a slowdown in issuance or widening spreads could translate directly into reduced lending capacity or capital pressure.
This is where SRTs could become procyclical amplifiers rather than stabilisers.
SRT structures are becoming more sophisticated, with increasing involvement from non-bank financial institutions, insurers and layered financing structures.
Individually, these components are well understood. In aggregate, they create risk transfer chains that are harder to monitor and model.
The lesson from previous cycles is clear:
complexity is rarely the problem in isolation—opacity is.
While investor leverage in SRT remains moderate today, it is embedded in the system. Financing structures, repo markets and fund-level leverage all play a role.
As the asset class matures, the risk is not immediate excess, but gradual normalisation of leverage assumptions, particularly if returns compress.
The report also reinforces the structural differences between jurisdictions. Europe continues to lead in SRT, supported by clearer regulatory frameworks, established market practices and greater standardisation. Within Europe, however, material differences remain with northern Europe lagging the south.
This matters.
A well-functioning SRT market requires:
Without this, scaling becomes difficult.
The BIS suggests the market could double in size. We would agree—but with an important caveat.
Growth will not be linear, it never is.
As SRT becomes more embedded in bank balance sheets, regulators will inevitably focus more closely on:
At the same time, investors will become more selective as structures evolve and complexity increases.
From our perspective, the next phase of SRT development will be defined by discipline, not just growth.
Three themes will be critical:
Transactions will increasingly be judged not just on capital efficiency, but on robustness under stress.
As SRT becomes a recurring tool, questions around incentives, control and downside protection will become more central.
Both regulators and investors will demand greater clarity on exposures, interlinkages and capital impact.
SRT has proven its value as a capital management tool across credit cycles. The question now is not whether it works—but how it scales.
Handled well, it can support lending, distribute risk efficiently and deepen capital markets. Handled poorly, it risks introducing the very vulnerabilities it was designed to mitigate.
The market is entering a phase where structure, governance and discipline will matter as much as growth.
That is where the real differentiation will be.
